Tonghua sells Iressa in India 15011127273 sells Tarceva in India

Distribution of Indian Iressa in Beijing, Indian Iressa price,
Consultation hotline: (Ms. Wang)
[Commodity name] Indian Iressa
[Common name] Gefitinib
[English trade name] b,
[English common name]
[Ingredients] Gefitinib
[Packaging/Dosage Form] Bottled, tablets.
【Character】: Brown, oval or round, biconvex, film-coated tablet with one side printed and the other side printed.
[Indications]: This product is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer that has previously received chemotherapy. Previous chemotherapy treatments mainly referred to platinum and docetaxel treatments.
[Usage and Dosage]: The recommended dosage of this product is (tablets), taken orally once a day, on an empty stomach or with food.
[Adverse Reactions] The most common (more frequent) adverse drug reactions are diarrhea, rash, itching, dry skin and acne, which are generally seen within the first month after taking the drug and are usually reversible. Approximately 10% of patients experienced serious adverse drug reactions (criterion 3 or grade). Only patients discontinued treatment due to adverse reactions.
[Storage/Validity Period] It should be kept below 3 years. Validity in years
[Product Specifications]*3 capsules
[Manufacturer] India. Pharmaceuticals Ltd., a pharmaceutical company with assets of hundreds of millions of rupees located in Hyderabad, is known for its research capabilities and timely release of technical information.
[Details]: Iressa (gefitinib) is an oral R tyrosine kinase inhibitor. It is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer that has previously received chemotherapy. reported that the objective response rate of patients with advanced disease receiving gefitinib monotherapy was ., and the median survival time was . months. Women, Asian patients with adenocarcinoma (especially alveolar cell carcinoma), and no history of smoking have a better prognosis. The company directly obtains medicines from Indian manufacturers. All medicines are produced by the original factory. The quality is absolutely guaranteed and the price is absolutely fair! Cash on delivery is supported nationwide and professional medication guidance is provided!
[British version of Iressa and Indian version Differences between Iressa versions]
The ingredients of the British version of Iressa and the Indian version are the same. The reason why Indian Iressa was officially launched in India is because of the use of different production processes.
Secondly, it is whether the effective content of the drug is stable. Because the dilution of the drug is carried out in batches multiple times, the process is very simple, and there should be no problem for a large factory like the Indian version of Iressa. (Pharmaceutical Group is the second largest group in India, and according to people in their company, it is the strongest in the world.) Moreover, India itself is a country with a very developed generic drug industry. As soon as expensive drugs produced by Western countries are put on the market, under the protection of its own patent laws, India can imitate the same drugs, and the relative price will be several times lower. This has greatly benefited hundreds of millions of Indian people who are also in developing countries.
Thirdly, it is the control of excipients, temperature, time, pH, bioavailability, etc. during the production process. For drugs that are greatly affected by the above factors, such as certain vitamins, etc., they will have a certain impact on the efficacy. However, from the packaging of Iressa and its taking method, it can be dissolved in boiling water before taking, indicating that Iressa is a relatively stable pharmaceutical preparation with stable bioavailability. For large manufacturers, the control of the production process will not be too difficult. So don't worry too much. Therefore, the quality of medicines produced in India is very reliable.
The company has a strict quality monitoring system to supervise the quality of its drugs. Each batch of drugs will be randomly inspected in accordance with regulations and must pass the test before leaving the factory.
Pharmaceuticals and pharmaceuticals are two pillar industries in India, and the company is a large group pharmaceutical company. However, they often face intellectual property disputes and are frequently brought to court by pharmaceutical companies in the United Kingdom and the United States. Last year, Tarceva was forced to suspend production. However, Gleevec and Iressa are not affected because the production license reports they submitted to the Indian government were earlier than the time when India implemented the world patent law.
Many patients ask why China cannot produce low-priced Iressa?
Many patients do not understand this because Iressa in the UK is expensive and few families can afford to pay tens of thousands of dollars per month for a long time. The cost of the drug is high, and even if Chinese pharmaceutical companies have the technology to synthesize gefitinib, they cannot obtain a production license for the national drug brand issued by the State Food and Drug Administration. The main reason is the issue of international intellectual property protection laws.